Immuneering Corporation

États‑Unis d’Amérique

Commandez votre montre hebdomadaire
Quantité totale PI 21
Rang # Quantité totale PI 71 393
Note d'activité PI 2,2/5.0    23
Rang # Activité PI 35 321
Symbole boursier IMRX (nasdaq)
ISIN US45254E1073
Capitalisation 67.70M  (USD)
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

4 4
2 0
10 1
0
 
Dernier brevet 2025 - Mek immune oncology inhibitors a...
Premier brevet 2008 - Determining disease or immune sy...
Dernière marque 2023 - DEEP CYCLIC INHIBITION
Première marque 2008 - IMMUNEERING

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Mek immune oncology inhibitors and therapeutic uses thereof. Methods of treating cancers with a c...
Invention Mek immune oncology inhibitor pharmaceutical compositions. Solid forms of 4-((dimcthylamino)mcthy...
Invention Inhibiting mitogen-activated protein (map)/erk kinase (mek)1 and mek2 and related methods of trea...
Invention Methods of treating cancer with a ras mutation. Methods of treating RAS-mutated cancers are provi...
2023 Invention Mek immune oncology inhibitors and therapeutic uses thereof. The present disclosure provides meth...
P/S chemical preparations and reagents for pharmaceutical, medical, and clinical purposes; pharmaceut...
Invention Mek immune oncology inhibitors and therapeutic uses thereof. The present disclosure provides com...
Invention Mek immune oncology inhibitors and therapeutic uses thereof. The present disclosure provides comp...
2022 P/S drug discovery services provided through a computer software platform used for research and devel...
2021 Invention Systems and methods for rapid gene set enrichment analysis. Systems and methods for rapid gene se...
Invention Mek inhibitors and therapeutic uses thereof. The present disclosure provides compounds, compositi...
2020 P/S Drug discovery services provided through a computer software platform used for research and deve...
2014 Invention Systems, methods, and environment for automated review of genomic data to identify downregulated ...
2011 Invention Methods of evaluating a subject's likelihood to respond to therapy based on analyzing relevant pa...
2010 Invention Method and system for assessing immune system response. A method and system for determining the ...
Invention Determining disease or immune system features based on analysis of immune system characteristics....
2009 Invention Method and system for assessing immune system response. A method and system for determining the e...
2008 P/S Providing medical information in the fields of therapy development, therapy selection, and therap...